Hillcrest HealthCare System

Congratulations to our structural heart team for completing their first procedures using the Abbott Navitor™ TAVR valve! Oklahoma Heart Institute is the first hospital in Oklahoma to use this technology, which is the newest TAVR valve platform to be approved in the United States. Transcatheter aortic valve replacement (TAVR) is a minimally-invasive, life-saving procedure for treatment of aortic stenosis, the narrowing of the main heart valve. We are thrilled about the ongoing technological advancements that we can use to assist our patients who struggle with aortic stenosis symptoms! OHI boasts the most comprehensive structural heart disease program in the state with access to cutting-edge clinical trials and FDA-approved therapies. To learn more about the services we offer, visit https://lnkd.in/gsWRKz7E.

Welcome to the beginning of your nursing career. Hillcrest Hospital South is hiring newly licensed RNs to join our accredited residency program! Our residency program is recognized by the American Nurses Credentialing Center (ANCC) as a Practice Transition Accreditation Program (PTAP and Pathway Designated. Join our team to learn from seasoned, caring nurses and kick-start your career today. Apply at https://bit.ly/3MiSYEh.

Graduate nurses, welcome to the beginning of your nursing career. At Hillcrest, we are dedicated to your success and development. Join our team to learn from seasoned, caring nurses and kick-start your career today. Apply at https://bit.ly/4cKChMQ.

Join our leadership team as Chief Operating Officer in Tulsa, OK! Make a local impact while benefiting from the expansive support of Ardent Health. Learn more about this exciting opportunity and apply today at https://lnkd.in/g3pVVSFA.

Oklahoma Heart Institute (OHI) is currently participating in the ALT-FLOW II clinical trial for patients experiencing heart failure symptoms. Congestive heart failure is a chronic condition that affects many people, with symptoms like shortness of breath, fatigue, swelling in the legs and ankles and difficulty exercising. This often limits heart failure patients from fully enjoying their lives. The ALT-FLOW II Trial evaluates a promising new therapy to implant a shunt in the heart, relieving heart failure symptoms. The investigational APTURE shunt device used in the trial is delivered without major surgery. It uses a catheter from the neck vein and is designed to reduce excess pressure in the heart that may be resulting in heart failure symptoms. Encouraging data from an early feasibility study of this device showed that patients had improvement in heart failure symptoms and increased exercise capacity. OHI is the only center in the region enrolling in this trial. Visit https://lnkd.in/gXk-96Mt to learn more. To learn more about clinical research at Oklahoma Heart Institute, please visit ohref.org.

After going through years of heart issues and noticing tightening in her chest and shortness of breath, Carol Hasselman turned to Dr. Kamran Muhammad and his team at Oklahoma Heart Institute (OHI) for help. They treated her tricuspid regurgitation, or leaky heart valve, with a new therapy: an EVOQUE valve. OHI is the only hospital in Oklahoma that offers this therapy commercially. Dr. Muhammad and Carol sat down with KJRH to talk about the procedure and how Carol's symptoms have improved thanks to the new technology.

Hillcrest is focused on the fight against lung cancer through early screenings. In honor of World Lung Cancer Day, we’re highlighting our recent participation in the Oklahoma Thoracic Oncology Program Summit. Our team spoke about the importance of building a high-quality lung program. In Oklahoma, the five-year survival rate for lung cancer is just 21%. Only 1.7% of high-risk patients are screened, which is significantly lower than the national rate of 4.5%. Hillcrest is committed to improving these statistics. Through collaboration, innovative care and community engagement, we can make a difference! Learn more at lungexam.com. #WorldLungCancerDay

Shortly after giving birth to her fifth child, C'ann Watson began experiencing unexplained chest pain. Not wanting to ignore the symptoms, her husband took her to Hillcrest South, where she went into cardiac arrest shortly after arriving. Dr. Stanley Zimmerman, cardiac catheterization lab director at Oklahoma Heart Institute, spoke to FOX23/KOKI's Michelle Linn about C'ann's condition, called SCAD, and explained what he and his team did to save her life that day. C'ann also shares why women shouldn't ignore cardiac symptoms and push for answers from their healthcare providers.

Hillcrest Medical Center is leading the way in Oklahoma in the early detection of lung cancer using our Ion robotic bronchoscopy system with more than 600 procedures completed. This minimally invasive method allows our providers to collect lung tissue samples, even when nodules are small, detecting lung cancer early and allowing time for intervention and advancement of care. HMC has two Ion robots and a CIOS Spin, used for 3-D imaging. Together these advancements in technology provide you with the most state-of-the-art medical care. If you are a current or former smoker who quit within the last 15 years, are between 50 and 80 years old or have a 20-pack-year smoking history, we recommend you schedule a lung screening. Visit lungexam.com to learn more.

Hillcrest South joins Hillcrest Medical Center as the only two Oklahoma hospitals to offer the revolutionary Intuitive da Vinci 5® surgical system, which is Intuitive’s most advanced and integrated platform designed to transform surgery to enable better outcomes, efficiency and actionable insights. Today, Dr. Jessica Koshy, OB-GYN, and team were the first to use the da Vinci 5, which is designed for a wide range of minimally invasive surgeries, including urology, gynecology, thoracic and general surgeries. This reaffirms Hillcrest's commitment to offering the highest standards of patient care and surgical precision to our patients.